Fact checked by Nick Blackmer Eli Lilly announced Tuesday that it is selling higher-dose vials of Zepbound at lower prices in ...

FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...

Last fall, before being named the senior U.S. health official, Robert F. Kennedy Jr. said the Trump administration would ...

In February 2025, a rumor spread online that Elon Musk, the technology mogul and public face of the new Department of ...

The MHRA reveals a staggering rise in deaths linked to weight loss and diabetes medications in the UK, with concerns over ...

Eli Lilly is expanding the supply and cutting the costs of its weight-loss drug Zepbound, broadening access to more patients ...

SLOW growth and the Covid-19 setbacks suffered by the economy could delay the country’s exit from the middle income trap, according to the National Economic and Development Authority (Neda). The ...

Medical treatments, including jabs used for weight loss, are monitored in part using the Medicines and Healthcare products ...

(Reuters) -Eli Lilly said on Tuesday it cut the price for vials of its weight-loss drug Zepbound by $50 or more and expanded ...

Hims & Hers projects $725M in GLP-1 weight loss revenue for 2025, a 3.2x increase from 2024. Read why I upgrade HIMS stock ...

The Food & Drug Administration announced last week that the Ozempic and Wegovy shortage for Novo Nordisk‘s (NYSE:NVO) was ...

Some people may turn to private healthcare providers in order to get their hands on the weight loss jabs. However, Britons ...